Yu K Peony 4
4 · FIBROGEN INC · Filed Mar 18, 2020
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Yu K Peony
VP, Clinical Development
Transactions
- Tax Payment
Common Stock
2020-03-06$39.71/sh−9,826$390,190→ 162,791 total - Exercise/Conversion
Common Stock
2020-03-16$19.39/sh+3,750$72,713→ 166,541 total - Award
Common Stock
2020-03-17+45,000→ 211,541 total - Award
Stock Option (Right to Buy)
2020-03-17+75,000→ 75,000 totalExercise: $26.41Exp: 2030-03-17→ Common Stock (75,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2020-03-16−3,750→ 56,250 totalExercise: $19.39Exp: 2026-02-22→ Common Stock (3,750 underlying)
Footnotes (4)
- [F1]Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
- [F2]Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years.
- [F3]Fully vested.
- [F4]Twenty-five percent of the shares subject to the option vests on March 1, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years.